(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 9.46% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.71%.
Caredx's revenue in 2025 is $357,998,000.On average, 11 Wall Street analysts forecast CDNA's revenue for 2025 to be $19,352,044,750, with the lowest CDNA revenue forecast at $18,503,920,533, and the highest CDNA revenue forecast at $20,030,441,259. On average, 11 Wall Street analysts forecast CDNA's revenue for 2026 to be $21,654,683,998, with the lowest CDNA revenue forecast at $19,879,229,300, and the highest CDNA revenue forecast at $22,977,531,473.
In 2027, CDNA is forecast to generate $24,196,485,018 in revenue, with the lowest revenue forecast at $22,681,793,799 and the highest revenue forecast at $25,928,736,299.